BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Bone cancer AND ERCC5, XPGC, 2073, ENSG00000134899, RP11-484I6_5, COFS3, XPG, UVDR, ERCM2
46516 results:

  • 1. bone mineral density as an individual prognostic biomarker in NSCLC patients treated with immune checkpoint inhibitors.
    Lou J; Gong B; Li Y; Guo Y; Li L; Wang J; Liu W; You Z; Zhang H; Pan F; Liang B; Yang L; Zhou G
    Front Immunol; 2024; 15():1332303. PubMed ID: 38698843
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Clinical outcomes of pomalidomide-based and daratumumab-based therapies in patients with relapsed/refractory multiple myeloma: A real-world cohort study in China.
    Han X; Jiang X; He J; Zheng G; Xiong Y; Wen Y; Yang Y; He D; Chen Q; Zhao Y; Li Y; Wu W; Cai Z
    Cancer Med; 2024 May; 13(9):e7232. PubMed ID: 38698679
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Three-dimensional printed custom-made modular talus prosthesis in patients with talus malignant tumor resection.
    He X; Lu M; Zou C; Li Z; Gong T; Kenmegne GR; Wang Y; Luo Y; Zhou Y; Min L; Tu C
    J Orthop Surg Res; 2024 May; 19(1):273. PubMed ID: 38698477
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Continuously improving outcome over time after second allogeneic stem cell transplantation in relapsed acute myeloid leukemia: an EBMT registry analysis of 1540 patients.
    Schmälter AK; Ngoya M; Galimard JE; Bazarbachi A; Finke J; Kröger N; Bornhäuser M; Stelljes M; Stölzel F; Tischer J; Schroeder T; Dreger P; Blau IW; Savani B; Giebel S; Esteve J; Nagler A; Schmid C; Ciceri F; Mohty M
    Blood Cancer J; 2024 May; 14(1):76. PubMed ID: 38697960
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Bioaccumulation and health risk assessment of trace elements in Tilapia (Oreochromis mossambicus) from selected inland water bodies.
    Balamanikandan V; Shalini R; Arisekar U; Shakila RJ; Padmavathy P; Sivaraman B; Devanesan S; Sundhar S; AlSalhi MS; Mythili R; Kim W
    Environ Geochem Health; 2024 May; 46(6):187. PubMed ID: 38696018
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Metastasis of small cell lung cancer to bilateral extraocular muscles: a case report.
    Ramalhão JP; Vieira BC; Rodrigues D; Afonso MG; Gouveia J; Baptista PM; Araújo M
    J Med Case Rep; 2024 May; 18(1):216. PubMed ID: 38693545
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Structure-sparing resection for the management of cervical chordomas: a retrospective institutional series.
    Levy AS; Jamshidi AM; Costello MC; Levi AD
    Neurosurg Focus; 2024 May; 56(5):E6. PubMed ID: 38691869
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Anatomical determinants of occipitocervical fusion in skull base chordoma resection: a systematic review of the literature with illustrative cases.
    Golub D; Küffer AF; Garrel S; Zandpazandi S; McBriar JD; Modi S; Papadimitriou K; Costantino PD; Sciubba DM; Dehdashti AR
    Neurosurg Focus; 2024 May; 56(5):E8. PubMed ID: 38691866
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Proton versus photon adjuvant radiotherapy: a multicenter comparative evaluation of recurrence following spinal chordoma resection.
    Ghaith AK; Nguyen R; El-Hajj VG; Montaser A; De Biase G; Ravindran K; Perez-Vega C; Lee SJ; Dominari A; Battistin U; Suárez-Meade P; Moussalem C; Patel NP; Kalani MA; Clarke MJ; Rose PS; Bydon M; Abode-Iyamah K; Akinduro OO
    Neurosurg Focus; 2024 May; 56(5):E9. PubMed ID: 38691864
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Optimizing radiotherapy strategies for skull base chordoma: a comprehensive meta-analysis and systematic review of treatment modalities and outcomes.
    Palavani LB; Borges P; Andreão FF; Borges J; Batista S; Oliveira LB; Ferreira MY; Reis PCA; Pontes J; Negri H; Beer-Furlan A; Krishna C; Bertani R; Rassi MS
    Neurosurg Focus; 2024 May; 56(5):E11. PubMed ID: 38691862
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Supramarginal resection of skull base chordomas: proof of concept and preliminary outcomes.
    Rychen J; Constanzo F; Xu Y; Johnstone TM; Bex A; Rinaldi M; Lee CK; Fernandez-Miranda JC
    Neurosurg Focus; 2024 May; 56(5):E3. PubMed ID: 38691859
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. A comparison of endoscopic endonasal versus open approaches for skull base chordoma: a comprehensive National cancer Database analysis.
    Soffer JM; Ulloa R; Chen S; Ziltzer RS; Patel VA; Polster SP
    Neurosurg Focus; 2024 May; 56(5):E5. PubMed ID: 38691856
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Quality of life in chordoma survivors: results from the Chordoma Foundation Survivorship Survey.
    Jimenez AE; Cicalese KV; Jimenez MA; Chakravarti S; Kuo CC; Lozinsky S; Schwab JH; Knowlton SE; Rowan NR; Mukherjee D
    Neurosurg Focus; 2024 May; 56(5):E12. PubMed ID: 38691854
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. The burden of skull base chordomas: insights from a meta-analysis of observational studies.
    Fiore G; Porto E; Bertani GA; Marcus HJ; Saladino A; Pradilla G; DiMeco F; Locatelli M
    Neurosurg Focus; 2024 May; 56(5):E13. PubMed ID: 38691853
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Long-term outcome of primary clival chordomas: a single-center retrospective study with an emphasis on the timing of recurrences based on the primary treatment.
    Hong S; Shinya Y; Mahajan A; Laack NN; O'Brien EK; Stokken JK; Janus JR; Raghunathan A; Link MJ; Van Gompel JJ
    Neurosurg Focus; 2024 May; 56(5):E4. PubMed ID: 38691852
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Plant-Based Diets and Disease Progression in Men With Prostate cancer.
    Liu VN; Van Blarigan EL; Zhang L; Graff RE; Loeb S; Langlais CS; Cowan JE; Carroll PR; Chan JM; Kenfield SA
    JAMA Netw Open; 2024 May; 7(5):e249053. PubMed ID: 38691361
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Phosphaturic mesenchymal tumor-induced bilateral osteomalacia femoral neck fractures: a case report.
    Zhang Y; Hu M; Guo C; Yang X; Xiang S; Xu H
    Front Endocrinol (Lausanne); 2024; 15():1373794. PubMed ID: 38689735
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. WNT5B drives osteosarcoma stemness, chemoresistance and metastasis.
    Perkins RS; Murray G; Suthon S; Davis L; Perkins NB; Fletcher L; Bozzi A; Schreiber SL; Lin J; Laxton S; Pillai RR; Wright AJ; Miranda-Carboni GA; Krum SA
    Clin Transl Med; 2024 May; 14(5):e1670. PubMed ID: 38689429
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Soft Tissue Reconstruction After Sacral Neoplasm Resection: The University of California San Francisco Experience.
    Falade IO; Knox JA; Piper ML; Hoffman WY; Hansen SL
    Ann Plast Surg; 2024 May; 92(5S Suppl 3):S320-S326. PubMed ID: 38689413
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Development and validation of a nomogram to predict surgical site infection after soft-tissue sarcoma resection.
    Miwa S; Yamamoto N; Hayashi K; Takeuchi A; Igarashi K; Tada K; Taniguchi Y; Morinaga S; Asano Y; Tsuchiya H
    Bone Joint J; 2024 May; 106-B(5):492-500. PubMed ID: 38688512
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2326.